These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 14966426)

  • 1. Macrophage colony-stimulating factor inhibits tumor necrosis factor production and prolongs skin graft survival.
    Nishina T; Naomoto Y; Gouchi A; Gunduz M; Shirakawa Y; Nobuhisa T; Motoki T; Kusaka S; Haisa M; Matsuoka J; Nakayama E; Tanaka N
    Transplantation; 2004 Feb; 77(3):456-59. PubMed ID: 14966426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine production-suppressive effect by macrophage colony-stimulating factor (M-CSF).
    Kojima K; Naomoto Y; Hizuta A; Tanaka N; Orita K
    Res Commun Mol Pathol Pharmacol; 1996 Feb; 91(2):161-72. PubMed ID: 8832908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies of effects of recombinant human tumor necrosis factor on autochthonous tumor and transplanted normal tissue in mice.
    McIntosh JK; Mulé JJ; Travis WD; Rosenberg SA
    Cancer Res; 1990 Apr; 50(8):2463-9. PubMed ID: 2317830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of tumour necrosis factor receptor-expressing macrophages by interleukin-10 and macrophage colony-stimulating factor in rheumatoid arthritis.
    Takasugi K; Yamamura M; Iwahashi M; Otsuka F; Yamana J; Sunahori K; Kawashima M; Yamada M; Makino H
    Arthritis Res Ther; 2006; 8(4):R126. PubMed ID: 16859503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colon cancer cell-derived tumor necrosis factor-alpha mediates the tumor growth-promoting response in macrophages by up-regulating the colony-stimulating factor-1 pathway.
    Zins K; Abraham D; Sioud M; Aharinejad S
    Cancer Res; 2007 Feb; 67(3):1038-45. PubMed ID: 17283136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage-colony stimulating factor is required for the production of neutrophil-promoting activity by mouse embryo fibroblasts deficient in G-CSF and GM-CSF.
    Zhang HH; Basu S; Wu F; Begley CG; Saris CJ; Dunn AR; Burgess AW; Walker F
    J Leukoc Biol; 2007 Oct; 82(4):915-25. PubMed ID: 17652450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of granulocyte-macrophage colony stimulating factor on nuclear factor-KappaB activation in multiple organs of hemorrhage-induced acute lung injury in mice].
    Wang Q; Song Y; Shi Y
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 May; 19(5):295-8. PubMed ID: 17490571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FK506 inhibits tumour necrosis factor-alpha secretion in human keratinocytes via regulation of nuclear factor-kappaB.
    Lan CC; Yu HS; Wu CS; Kuo HY; Chai CY; Chen GS
    Br J Dermatol; 2005 Oct; 153(4):725-32. PubMed ID: 16181452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage-colony stimulating factor in obese adipose tissue: studies with heterozygous op/+ mice.
    Sugita S; Kamei Y; Oka J; Suganami T; Ogawa Y
    Obesity (Silver Spring); 2007 Aug; 15(8):1988-95. PubMed ID: 17712116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of osteoprotegerin production in bone marrow macrophages by macrophage colony-stimulating factor.
    Yamada N; Tsujimura T; Ueda H; Hayashi S; Ohyama H; Okamura H; Terada N
    Cytokine; 2005 Aug; 31(4):288-97. PubMed ID: 15996478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roflumilast inhibits lipopolysaccharide-induced inflammatory mediators via suppression of nuclear factor-kappaB, p38 mitogen-activated protein kinase, and c-Jun NH2-terminal kinase activation.
    Kwak HJ; Song JS; Heo JY; Yang SD; Nam JY; Cheon HG
    J Pharmacol Exp Ther; 2005 Dec; 315(3):1188-95. PubMed ID: 16126838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of allograft rejection by applying a novel nuclear factor-kappaB inhibitor, dehydroxymethylepoxyquinomicin.
    Ueki S; Yamashita K; Aoyagi T; Haga S; Suzuki T; Itoh T; Taniguchi M; Shimamura T; Furukawa H; Ozaki M; Umezawa K; Todo S
    Transplantation; 2006 Dec; 82(12):1720-7. PubMed ID: 17198266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
    Shimizu H; Takahashi M; Kaneko T; Murakami T; Hakamata Y; Kudou S; Kishi T; Fukuchi K; Iwanami S; Kuriyama K; Yasue T; Enosawa S; Matsumoto K; Takeyoshi I; Morishita Y; Kobayashi E
    Circulation; 2005 Jan; 111(2):222-9. PubMed ID: 15642767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of tumor necrosis factor by macrophage colony-stimulating factor in vivo.
    Zhu D; Zhang H; Gao N; Tao X; Han K; Shing Y
    J Biol Response Mod; 1990 Jun; 9(3):339-42. PubMed ID: 2199615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum levels of macrophage-colony stimulating factor (M-CSF): a marker of kidney allograft rejection.
    Le Meur Y; Leprivey-Lorgeot V; Mons S; José M; Dantal J; Lemauff B; Aldigier JC; Leroux-Robert C; Praloran V
    Nephrol Dial Transplant; 2004 Jul; 19(7):1862-5. PubMed ID: 15150350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotine and lipopolysaccharide stimulate the formation of osteoclast-like cells by increasing macrophage colony-stimulating factor and prostaglandin E2 production by osteoblasts.
    Tanaka H; Tanabe N; Shoji M; Suzuki N; Katono T; Sato S; Motohashi M; Maeno M
    Life Sci; 2006 Mar; 78(15):1733-40. PubMed ID: 16266722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage colony stimulating factor (M-CSF) exacerbates ALS disease in a mouse model through altered responses of microglia expressing mutant superoxide dismutase.
    Gowing G; Lalancette-Hébert M; Audet JN; Dequen F; Julien JP
    Exp Neurol; 2009 Dec; 220(2):267-75. PubMed ID: 19733170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activities of granulocyte-macrophage colony-stimulating factor and interleukin-3 on monocytes.
    Suzuki H; Katayama N; Ikuta Y; Mukai K; Fujieda A; Mitani H; Araki H; Miyashita H; Hoshino N; Nishikawa H; Nishii K; Minami N; Shiku H
    Am J Hematol; 2004 Apr; 75(4):179-89. PubMed ID: 15054806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage colony-stimulating factor (M-CSF), as well as granulocyte colony-stimulating factor (G-CSF), accelerates neovascularization.
    Minamino K; Adachi Y; Okigaki M; Ito H; Togawa Y; Fujita K; Tomita M; Suzuki Y; Zhang Y; Iwasaki M; Nakano K; Koike Y; Matsubara H; Iwasaka T; Matsumura M; Ikehara S
    Stem Cells; 2005 Mar; 23(3):347-54. PubMed ID: 15749929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The activity of inducible nitric oxide synthase in rejected skin xenografts is selectively inhibited by a factor produced by grafted cells.
    Holán V; Pindjáková J; Zajícová A; Krulová M; Zelezná B; Matousek P; Svoboda P
    Xenotransplantation; 2005 May; 12(3):227-34. PubMed ID: 15807773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.